Clinical Trials Sponsored by Guido Tricot

Total 168 results

Guido Tricot
National Cancer Institute (NCI)

Completed

Tandem Transplantation in Multiple Myeloma (MM) Patients With <12 Months of Prior Treatment

Multiple Myeloma
Guido Tricot
Otsuka Pharmaceutical Development & Commercialization, Inc.

Terminated

Busulfan in Multiple Myeloma

Multiple Myeloma
Davidzon, Guido, M.D.

Terminated

18F-FTC-146 PET/CT in Newly-Diagnosed Osteosarcoma

Osteosarcoma

United States
Davidzon, Guido, M.D.
Stanford University

Suspended

Does rTMS Induce Synaptic Plasticity?

Major Depressive Disorder

United States
Pharma Guide CRO

Completed

Comparative Randomized, Single Dose, Two-way Crossover Open-label Study to Determine the Bioequivalence of Gabapentin From Nerpentin 600 mg (Test ) F.C.T (Aman Pharma ,Egypt.) and Gabapentin From Neurontin 300 mg (Referance ) H.G.C. ( Pfizer Egypt)

Healthy

Egypt
Guido A. Davidzon, MD, SM

Completed

[18F]DASA-23 and PET Scan in Evaluating Pyruvate Kinase M2 Expression in Patients With Intracranial Tumors or Recurrent Glioblastoma and Healthy Volunteers

Glioblastoma | Healthy Subject | Intracranial Neoplasm

United States
Istituto Oncologico Veneto IRCCS
Fondazione Guido Berlucchi

Completed

Totally Implantable Venous Access Devices: Quality of Life and Body Image (BI-PORT)

Neoplasms Undergoing Chemotherapy

Italy
Guido A. Davidzon, MD, SM

Withdrawn

Novel Clinical Target in Fragile X Syndrome

Fragile X Syndrome (FXS)

United States
Tricog Health Inc

Not yet recruiting

Guideline Directed Medical Therapy (GDMT) Optimization and Adherence Longitudinal Study for Heart Failure. (GOALS-HF)

Heart Failure

United States, India
Davidzon, Guido, M.D.
Weston Havens Foundation

Recruiting

Imaging Synapses With [11C] UCB-J in the Human Brain

Schizophrenia

United States
Gaido Health
The Guthrie Clinic

Unknown

Remote Electronic Patient Monitoring in Oncology Patients

Cancer

United States
Clear Guide Medical
University of Maryland

Withdrawn

Modality Augmentation for Navigation: Intuitive Fusion With Optical Lightweight Device (US/MR) (MANIFOLD I)

Renal Biopsy or Ablation
Clear Guide Medical
Johns Hopkins University

Unknown

Ultrasound-CT Fusion System for Interventional Radiology Procedures

CT Guided Biopsy | CT Guided Drain Placement Within the Abdomen or Pelvis | CT Guided Injection of Muscle or Nerve Within the Pelvis

United States
Clear Guide Medical
Johns Hopkins University

Withdrawn

Modality Augmentation for Navigation: Intuitive Fusion With Optical Lightweight Device (US/CBCT) (MANIFOLD II)

Hepatic Biopsy or Ablation
Xuanwu Hospital, Beijing
Guidon Pharmaceutics Ltd.

Not yet recruiting

The Effect of GD-iExo-003 in Acute Ischemic Stroke (ExoCURE)

Acute Ischemic Stroke
Mayo Clinic
Clear Guide Medical Inc.

Enrolling by invitation

A Study of Optical Fusion Trans-Perineal Grid

Prostate Biopsy

United States
Clear Guide Medical
University of Miami

Completed

Training and Evaluation of Ultrasound-Guided Procedures

Learning Anesthesia Procedures

United States
University of Padova
Istituto Oncologico Veneto IRCCS; Fondazione Guido Berlucchi

Terminated

Quality of Life After Esophagectomy for Cancer - Step 1

Quality of Life | Esophageal Cancer | Sleep Disturbance

Italy
Trisol Medical

Recruiting

Trisol System EFS Study

Tricuspid Regurgitation

United States
Tricore, Inc

Not yet recruiting

Evaluation of a Screen and Treat Protocol for Influenza

Influenza
Clear Guide Medical
The Cooper Health System

Completed

Computer Assisted Instrument Guidance (CAIG) for Orthopedic Peripheral Nerve Blocks

Peripheral Nerve Blocks

United States
Clear Guide Medical
The Cooper Health System

Completed

Computer Assisted Instrument Guidance (CAIG) For Arterial Line Placement

Arterial and Midline Catheterization

United States
Clear Guide Medical
Children's National Research Institute

Completed

Image Guidance for Improved Vessel Cannulation in Pediatric Patients

Central Vein Cannulation

United States
Guido Iaccarino

Completed

Fixed vs Free Dose of ACEi/CCB Combination Therapy (FixFree)

Hypertension

Italy
Tracon Pharmaceuticals Inc.

Recruiting

ENVASARC: Envafolimab And Envafolimab With Ipilimumab In Patients With Undifferentiated Pleomorphic Sarcoma Or Myxofibrosarcoma (ENVASARC)

Undifferentiated Pleomorphic Sarcoma | Myxofibrosarcoma

United States, United Kingdom
Tracon Pharmaceuticals Inc.

Terminated

Randomized Phase 2 Trial of Axitinib and TRC105 Versus Axitinib Alone in Patients Renal Cell Carcinoma

Renal Cell Carcinoma

United States, Hungary, Czechia, United Kingdom
Tracon Pharmaceuticals Inc.

Completed

Trial of TRC105 and Pazopanib Versus Pazopanib Alone in Patients With Advanced Angiosarcoma (TAPPAS)

Advanced Angiosarcoma

United States, France, Italy, Austria, Germany, Poland, Spain, United Kingdom
Tracon Pharmaceuticals Inc.

Completed

TRC105 Combined With Standard-dose Bevacizumab for Two Patients With Metastatic And Refractory Choriocarcinoma

Choriocarcinoma

United States
Tracon Pharmaceuticals Inc.

Completed

Open Label Phase 1 Dose Finding Study of TRC105 in Patients With Solid Cancer

Cancer | Neoplasm Metastasis

United States
Tracon Pharmaceuticals Inc.

Completed

Phase 1, Open-label, Dose Escalation Study of TRC093, in Patients With Locally Advanced or Metastatic Solid Tumors

Cancer | Neoplasm Metastasis

United States
Tracon Pharmaceuticals Inc.

Active, not recruiting

Study of TJ004309 in Combination With Atezolizumab (Tecentriq®) in Patients With Advanced or Metastatic Cancer

Solid Tumor | Metastatic Cancer

United States
Tracon Pharmaceuticals Inc.

Completed

Trial of TRC105 and Sorafenib in Patients With HCC

Hepatocellular Carcinoma

United States
Tracon Pharmaceuticals Inc.

Completed

Study of Carotuximab (TRC105) Plus Nivolumab in Patients With Metastatic NSCLC

Carcinoma, Non-Small-Cell Lung

United States
Tracon Pharmaceuticals Inc.

Completed

A Phase 1B Dose-escalation and Phase 2a Study of Carotuximab (TRC105) in Combination With Pazopanib in Patients With Advanced Soft Tissue Sarcoma

Advanced Soft Tissue Sarcoma

United States
Tracon Pharmaceuticals Inc.

Terminated

Study of TRC105 and Bevacizumab in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN)

Gestational Trophoblastic Neoplasia | Choriocarcinoma | Placental Site Trophoblastic Tumor | Epithelioid Trophoblastic Tumor

United States
Tracon Pharmaceuticals Inc.

Completed

Evaluation of TRC105 in the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

Fallopian Tube Carcinoma | Primary Peritoneal Carcinoma | Recurrent Ovarian Cancer

United States
Tracon Pharmaceuticals Inc.

Completed

Study of TRC105 Combined With Standard-Dose Bevacizumab for Advanced Solid Tumors for Which Bevacizumab is Indicated

Adult Solid Tumor

United States
Guido Iaccarino

Recruiting

Observatory on Impact of Life Styles on Health Outcomes (OIVITA)

Outcome

Italy
University of Padova
Fondazione Guido Berlucchi; Veneto Institute of Oncology I.O.V.-I.R.C.C.S.

Terminated

Quality of Life After Esophagectomy for Cancer - Step 2

Quality of Life | Esophageal Cancer

Italy
Peking Union Medical College Hospital
Guidon Pharmaceutics Ltd.

Recruiting

Induced Pluripotent Stem Cell Derived Exosomes for the Treatment of Atopic Dermatitis

Atopic Dermatitis

China
Peking Union Medical College Hospital
Guidon Pharmaceutics Ltd.

Recruiting

Induced Pluripotent Stem Cell Derived Exosomes Nasal Drops for the Treatment of Refractory Focal Epilepsy

Refractory Focal Epilepsy

China
Dicot AB

Active, not recruiting

A Phase 1 Trial of LIB-01 in Healthy Participants.

Erectile Dysfunction

Sweden
Tracon Pharmaceuticals Inc.

Active, not recruiting

YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic Sarcoma

Soft Tissue Sarcoma | Advanced Sarcoma | Metastatic Sarcoma

United States
Tracon Pharmaceuticals Inc.

No longer available

Open Label Continuation Study of TRC105 for Patients Who Have Completed a Prior TRC105 Trial

Solid Tumors

United States
Tracon Pharmaceuticals Inc.

Completed

Study of TRC102 in Combination With Pemetrexed in Cancer Patients

Neoplasm

United States
Tri.O Medical LTD

Recruiting

Proof of Concept Open Label, Clinical Trial to Evaluate the Safety and Efficacy of the "FITT" Device in Diabetic Foot Ulcers Patients (TriO FITT)

Diabetic Foot Ulcer

Israel
Clear Guide Medical
National Institutes of Health (NIH); Temple University

Withdrawn

Novel Guidance Device for Image Fusion and Needle Guidance in Lung, Liver or Kidney Biopsy

Liver Biopsy | Lung Biopsy | Kidney Biopsy

United States
University of Florence
Prof Sandro Gelsomino; Prof Edvin Prifti; Prof Guido Sani; Dr Aleksander Dokollari

Recruiting

Mini-invasive Approaches to Aortic Surgery (MSvsMT)

Surgery | Surgical Incision | Surgical Injury | Surgical Procedure, Unspecified | Aortic Surgery

Italy
Ricoh USA, Inc.

Recruiting

A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning

Osteosarcoma | Sarcoma, Ewing | Chondrosarcoma | Fibrosarcoma | Fibrous Histiocytoma

United States
Massachusetts General Hospital
Crico

Completed

Telemedicine Abdominal Exams & Imaging

Abdominal Pain

United States

Clinical Trials Sponsored by Guido Tricot

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cote d'Ivoire

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations